Facebook Pixel Taking Science Into Their Own Hands | Newsweek US - news - Lisez cet article sur Magzter.com

Essayer OR - Gratuit

Taking Science Into Their Own Hands

Newsweek US

|

August 01 - 08, 2025 (Double Issue)

In the race to treat rare disease, families are leading the charge to find cures themselves

- by ALEXIS KAYSER

Taking Science Into Their Own Hands

WHEN CASEY MCPHERSON became a father, his purpose became clear. He needed to raise his daughter, Rose, to be loving, courageous, healthy and strong. He needed to protect her.

So when the pediatric neurologist told McPherson that Rose had a rare genetic disease—so uncommon that it didn’t even have a name—parental instinct kicked in. And when the doctor said: “There’s nothing we can do,” that instinct sharpened.

“Rose was being attacked, but there wasn’t a monster for me to kill or a car for me to throw myself in front of,” McPherson told Newsweek. “It was just one little nucleotide in the gene. And if that’s the monster for me to kill, then that’s the monster I’m going after.”

Rose, now 9, and McPherson, 46, fight against that “monster” disease in little ways each day. Their home in a suburb of Austin, Texas, is “Rosie-proofed,” as McPherson said. She sleeps in a special bed equipped with barriers to keep her from wandering off, and a video camera plus oxygen and pulse monitors scan for signs of seizures in the night. Rose doesn’t have the restraint of a neurotypical 9-year-old, so chemicals and electronics are kept behind three levels of locks. She takes seizure medication twice a day, and goes to a private school for children with special needs (paid for out of pocket, because there was a 15-year waiting list for any sort of financial assistance).

Before, McPherson was known as the frontman of the alternative rock bands Alpha Rev and Flying Colors. After Rose’s diagnosis in 2016, he took on a new role as a founder, launching the nonprofit To Cure a Rose Foundation, the contract research organization Everlum Bio and now the public benefit corporation AlphaRose Therapeutics. All three seek to find and fund cures for children with exceedingly rare genetic diseases, like Rose’s.

McPherson is among a rising number of parents, spouses and patients seeking cures for rare diseases. Many of them are not scientists or doctors.

PLUS D'HISTOIRES DE Newsweek US

Newsweek US

Newsweek US

WILL SHARPE

The actor has been on a roll since White Lotus, and his latest role as Wolfgang Amadeus Mozart in the Starz limited series Amadeus may be his “most exciting challenge” yet

time to read

2 mins

July 03, 2026

Newsweek US

Newsweek US

From Root to Tree

As executive producer, Brooke Shields had her hand in everything on You're Killing Me

time to read

1 min

July 03, 2026

Newsweek US

Newsweek US

SHINMEI Strengthens Japan's Food Security Globally

SHINMEI Holdings is linking overseas demand for Japanese food with domestic agricultural renewal, using innovation, exports and producer support to strengthen Japan's food security.

time to read

4 mins

July 03, 2026

Newsweek US

Newsweek US

UNCOMMON KNOWLEDGE Emperor's New Clothes

President Donald Trump marked his 80th birthday by turning the White House into a fight venue-prompting familiar Roman emperor comparisons.

time to read

1 mins

July 03, 2026

Newsweek US

Newsweek US

From Shinkansen Icon to Global Sensation: Bringing Japan’s Premium Ice Cream Experience to the World

Sujahta Meiraku aims to export the premium quality and unique experience of its signature “Shinkansen ice cream” through tourism-driven retail and experiential dessert concepts worldwide.

time to read

4 mins

July 03, 2026

Newsweek US

Newsweek US

A Victory off the Pitch

China didn't qualify for the FIFA World Cup, but that hasn't stopped its brands performing.

time to read

1 min

July 03, 2026

Newsweek US

Newsweek US

Socials Win Clicks as Trust Takes a Hit

The numbers tell a striking story-and hint at a deeper shift in how people relate to news.

time to read

1 min

July 03, 2026

Newsweek US

Newsweek US

ANSWERING THE CALL

With theatrical rom-coms nearly extinct, Netflix is finding success building the genre’s new home

time to read

2 mins

July 03, 2026

Newsweek US

Newsweek US

The Feed Doesn't Follow House Rules

A parent can pick up their kid's phone and find an impossible assignment waiting: monitor every app, feed, stranger, algorithmic nudge, sleepless doomscroll.

time to read

1 min

July 03, 2026

Newsweek US

Newsweek US

RUFFLED FEATHERS

A $1.4 billion Jared Kushner-backed resort is putting Albania’s EU ambitions, its rule of law and its flamingos on the line

time to read

5 mins

July 03, 2026

Listen

Translate

Share

-
+

Change font size